Showing 97–108 of 109 results
As more is learned about the intricacies of GPCR signaling, the harder it becomes to accurately describe ligand activity using…
Read MoreThe development of antibody-based therapeutics to target the killing of tumor cells has revolutionized the space of immuno-oncology and the…
Read MoreRobust, Ready-to-Use ADCC & ADCP Bioassays to Accelerate Your Drug Development Program The KILR® cytotoxicity assay platform developed by Eurofins…
Read MoreWith a growing list of over 150 customer publications, PathHunter® Arrestin assays are among the most trusted functional GPCR assays…
Read MoreComprehensive Eurofins DiscoverX product list to enable your drug discovery and development programs focused on checkpoint receptors, cytokine receptors/interleukins, cytotoxicity,…
Read MoreHere, we present data for the ready-to-use PathHunter® Checkpoint assays that target clinically relevant co-inhibitory and co-stimulatory checkpoint receptors and…
Read MoreAn Application Note on automating Eurofins DiscoverX Cell-Based PathHunter® PD-1 Signaling Bioassay to bring high-throughput efficiencies to assay workflows. The…
Read MoreLearn how to confidently de-risk your biologics’ lot-release strategy by establishing a dedicated analytical cell banks for your bioassay. Find…
Watch NowAuthors: Kramer J, Himmel HM, Lindqvist A, Stoelzle-Feix S, Chaudhary KW, Li D, Bohme GA, Bridgland-Taylor M, Hebeisen S, Fan…
Read MoreApplication of GPCR Pharmacotrafficking & Cell-Based Assays
Read MoreBiosafety Information Document – Stable Cell Lines and Cell Pools
Read MoreClass I therapeutic antibodies achieve their clinical efficacy not only by binding to their target antigen but also through Fc…
Read More
